Predictive Oncology Inc. (POAI)

USD 0.73

(-1.35%)

Revenue Summary of Predictive Oncology Inc.

  • Predictive Oncology Inc.'s latest annual revenue in 2023 was 1.78 Million USD , up 18.24% from previous year.
  • Predictive Oncology Inc.'s latest quarterly revenue in 2024 Q2 was 278.72 Thousand USD , down -33.58% from previous quarter.
  • Predictive Oncology Inc. reported a annual revenue of 1.5 Million USD in annual revenue 2022, up 5.97% from previous year.
  • Predictive Oncology Inc. reported a annual revenue of 1.42 Million USD in annual revenue 2021, up 13.45% from previous year.
  • Predictive Oncology Inc. reported a quarterly revenue of 419.64 Thousand USD for 2024 Q1, up 25.26% from previous quarter.
  • Predictive Oncology Inc. reported a quarterly revenue of 239.89 Thousand USD for 2023 Q1, down -34.0% from previous quarter.

Annual Revenue Chart of Predictive Oncology Inc. (2023 - 2008)

Historical Annual Revenue of Predictive Oncology Inc. (2023 - 2008)

Year Revenue Revenue Growth
2023 1.78 Million USD 18.24%
2022 1.5 Million USD 5.97%
2021 1.42 Million USD 13.45%
2020 1.25 Million USD -11.28%
2019 1.41 Million USD -0.01%
2018 1.41 Million USD 115.57%
2017 654.83 Thousand USD 43.45%
2016 456.49 Thousand USD -30.24%
2015 654.35 Thousand USD -31.23%
2014 951.55 Thousand USD 103.27%
2013 468.12 Thousand USD 147.98%
2012 188.77 Thousand USD 95.34%
2011 96.63 Thousand USD 33454.51%
2010 288.00 USD -98.17%
2009 15.73 Thousand USD 0.0%
2008 - USD 0.0%

Peer Revenue Comparison of Predictive Oncology Inc.

Name Revenue Revenue Difference
Akoya Biosciences, Inc. 96.63 Million USD 98.158%
AngioDynamics, Inc. 303.91 Million USD 99.414%
AtriCure, Inc. 399.24 Million USD 99.554%
Avinger, Inc. 7.65 Million USD 76.737%
Azenta, Inc. 665.07 Million USD 99.732%
BioLife Solutions, Inc. 143.27 Million USD 98.758%
The Cooper Companies, Inc. 3.59 Billion USD 99.95%
Daxor Corporation 1.28 Million USD -39.014%
Ekso Bionics Holdings, Inc. 18.27 Million USD 90.262%
Femasys Inc. 1.07 Million USD -66.058%
GlucoTrack, Inc. - USD -Infinity%
Harvard Bioscience, Inc. 112.25 Million USD 98.414%
Hologic, Inc. 4.03 Billion USD 99.956%
ICU Medical, Inc. 2.25 Billion USD 99.921%
Intuitive Surgical, Inc. 7.12 Billion USD 99.975%
KORU Medical Systems, Inc. 28.51 Million USD 93.758%
LeMaitre Vascular, Inc. 193.48 Million USD 99.08%
Innovative Eyewear, Inc. 1.15 Million USD -54.458%
Innovative Eyewear, Inc. 1.15 Million USD -54.458%
Masimo Corporation 2.04 Billion USD 99.913%
Microbot Medical Inc. - USD -Infinity%
Meihua International Medical Technologies Co., Ltd. 97.09 Million USD 98.167%
Merit Medical Systems, Inc. 1.25 Billion USD 99.858%
Nephros, Inc. 14.23 Million USD 87.498%
NovoCure Limited 509.33 Million USD 99.651%
NEXGEL, Inc. 4.08 Million USD 56.466%
NEXGEL, Inc. 4.08 Million USD 56.466%
Singular Genomics Systems, Inc. 2.91 Million USD 38.849%
OraSure Technologies, Inc. 405.47 Million USD 99.561%
Pro-Dex, Inc. 53.84 Million USD 96.694%
Pulse Biosciences, Inc. - USD -Infinity%
Precision Optics Corporation, Inc. 19.1 Million USD 90.682%
QuidelOrtho Corporation 2.99 Billion USD 99.941%
Repligen Corporation 638.76 Million USD 99.721%
Sanara MedTech Inc. 64.98 Million USD 97.261%
STAAR Surgical Company 322.41 Million USD 99.448%
Sharps Technology, Inc. - USD -Infinity%
Utah Medical Products, Inc. 50.22 Million USD 96.456%
DENTSPLY SIRONA Inc. 3.96 Billion USD 99.955%
Jin Medical International Ltd. 19.82 Million USD 91.019%